Cyrus Biotechnology Raises $8M Series A Led by Trinity Ventures to Expand Cloud-Based Protein Modeling for Drug Discovery

Cyrus Biotechnology secured $8 million in Series A funding led by Trinity Ventures to advance its cloud-based protein modeling platform, Cyrus Bench, which aids drug discovery. The software builds on the University of Washington's Rosetta platform, enabling researchers to design novel protein configurations for therapeutic applications.

CCyrus Biotechnology TThe W Fund